Lonza Group
€722.40
213
-€4.40-0.61%Friday 20:46
Statistics
Day High
727.6
Day Low
715.4
52W High
736.8
52W Low
499.1
Volume
66
Avg. Volume
-
Mkt Cap
50.46B
P/E Ratio
-
Dividend Yield
0.38%
Dividend
2.73
Upcoming
Dividends
0.38%Dividend Yield
May 2026
€2.73
May 2026
€2.73
May 2025
€2.14
May 2025
€2.14
May 2024
€2.04
10Y Growth
N/A
5Y Growth
17.77%
3Y Growth
15.08%
1Y Growth
27.74%
Earnings
Jan 27Expected
Q4 2025
Q2 2026
Next
8.8
9.26
9.71
10.16
Expected EPS
10.162853085
Actual EPS
N/A
Financials
-4.24%Profit Margin
Unprofitable7BRevenue
-297.02MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow LO3.STU. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Thermo Fisher Scientific
TMO
Mkt Cap257.71B
Danaher
DHR
Mkt Cap163.25B
Charles River Laboratories International
CRL
Mkt Cap17.16B
IQVIA
IQV
Mkt Cap44.06B
West Pharmaceutical Services
WST
Mkt Cap28.74B
Bio-Rad Laboratories
BIO
Mkt Cap9.95B
About
Lonza Group AG, together with its subsidiaries, operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Integrated Biologics; Advanced Synthesis; and Specialized Modalities segments. The Integrated Biologics segment offers CDMO biologics services from clinical development, drug substance, and drug product manufacturing; and operates mammalian and drug product platforms. Its Advanced Synthesis segment manufactures antibody-drug conjugates (ADCs) and other bioconjugates, small molecules, and highly potent active pharmaceutical ingredients; and operates small molecules and bioconjugates platforms. The Specialized Modalities segment operates various technologies, such as spanning cell & gene, microbial, bioscience, and mRNA. Lonza Group AG was incorporated in 1897 and is headquartered in Basel, Switzerland.
Show More
CEO
Wolfgang Wienand
Employees
16866
Country
Switzerland
ISIN
CH0013841017
WKN
000928619
Listings
0 Comments
Share your thoughts
FAQs
What is Lonza Group stock price today?▼
The current price of LO3.STU is €722.40 EUR — it has decreased by -0.61% in the past 24 hours. Watch Lonza Group stock price performance more closely on the chart.
What is Lonza Group stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange Lonza Group stocks are traded under the ticker LO3.STU.
Is Lonza Group stock price growing?▼
LO3.STU stock has risen by +3.35% compared to the previous week, the month change is a +16.52% rise, over the last year Lonza Group has showed a +27.27% increase.
What is Lonza Group market cap?▼
Today Lonza Group has the market capitalization of 50.46B
When is the next Lonza Group earnings date?▼
Lonza Group is going to release the next earnings report on January 27, 2027.
What were Lonza Group earnings last quarter?▼
LO3.STU earnings for the last quarter are 8.85 EUR per share, whereas the estimation was 9.43 EUR resulting in a -6.19% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Lonza Group revenue for the last year?▼
Lonza Group revenue for the last year amounts to 7B EUR.
What is Lonza Group net income for the last year?▼
LO3.STU net income for the last year is -297.02M EUR.
Does Lonza Group pay dividends?▼
Yes, LO3.STU dividends are paid annual. The last dividend per share was 2.73 . As of today, Dividend Yield (FWD)% is 0.38%.
How many employees does Lonza Group have?▼
As of November 7, 2026, the company has 16,866 employees.
In which sector is Lonza Group located?▼
Lonza Group operates in the Health & Wellness sector.
When did Lonza Group complete a stock split?▼
Lonza Group has not had any recent stock splits.
Where is Lonza Group headquartered?▼
Lonza Group is headquartered in Basel, Switzerland.